Brimonidine - DermNet
Aug 1, 2013 · Brimonidine is the first and only FDA-approved topical treatment specifically developed and indicated for facial erythema in rosacea. Applied once daily, brimonidine works …
Key clinical-trial evidence for brimonidine - DermNet
Aug 1, 2013 · The approval of brimonidine topical gel was based on data collected from more than 550 patients enrolled in two phase 3 clinical studies, each of one-month duration. The results …
Poikiloderma of Civatte
What is poikiloderma of Civatte? Poikiloderma of Civatte is a benign, common and chronic condition, which belongs to the group of melanodermas (pigmented skin disorders).
Rosacea: Symptoms, Causes, and Management - DermNet
Alpha-adrenergic agonists (topical brimonidine, topical oxymetazoline) — they are often used infrequently for special occasions only, as persistent use may result in rebound flushing on …
45-year-old with progressive facial discolouration - DermNet
A 45-year-old male presented with progressive discolouration on both sides of his face for one year. He reported no pain or itch. Of note, the patient worked as an automobile salesperson.
Topical skin treatments - DermNet
Topical skin treatments. Authoritative facts about the skin from DermNet New Zealand.